Creatine transporter expression after antidepressant therapy in rats bred for learned helplessness

References

• Braissant O, Henry H, Loup M, Eilers B, Bachmann C. Endogenous synthesis and transport of creatine in the rat brain: an in situ hybridization study. Brain Res Mol Brain Res 2001; 86(1–2)193–201
   PubMedGoogle Scholar
• Cecil KM, Salomons GS, Ball WS, Jr, Wong B, Chuck G, Verhoeven NM, et al. Irreversible brain creatine deficiency with elevated serum and urine creatine: a creatine transporter defect?. Ann Neurol 2001; 49(3)401–404
   PubMedGoogle Scholar
• Czeh B, Michaelis T, Watanabe T, Frahm J, de Biurrun G, van Kampen M, et al. Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proc Natl Acad Sci USA 2001; 98(22)12796–12801
   PubMed Web of Science ®Google Scholar
• Dechent P, Pouwels PJ, Wilken B, Hanefeld F, Frahm J. Increase of total creatine in human brain after oral supplementation of creatine-monohydrate. Am J Physiol 1999; 277(3 Pt 2)R698–704
   PubMed Web of Science ®Google Scholar
• Ende G, Braus DF, Walter S, Weber-Fahr W, Henn FA. The hippocampus in patients treated with electroconvulsive therapy: a proton magnetic resonance spectroscopic imaging study. Arch Gen Psychiatry 2000; 57(10)937–943
   PubMed Web of Science ®Google Scholar
• Gall C, Lauterborn J, Bundman M, Murray K, Isackson P. Seizures and the regulation of neurotrophic factor and neuropeptide gene expression in brain. Epilepsy Res Suppl 1991; 4: 225–245
   PubMedGoogle Scholar
• Henn FA, Vollmayr B. Stress models of depression: forming genetically vulnerable strains. Neurosci Biobehav Rev 2005; 29(4–5)799–804
   PubMed Web of Science ®Google Scholar
• Klerman GL, Weissman MM. The course, morbidity, and costs of depression. Arch Gen Psychiatry 1992; 49(10)831–834
   PubMed Web of Science ®Google Scholar
• Kozisek ME, Deupree JD, Burke WJ, Bylund DB. Appropriate dosing regimens for treating juvenile rats with desipramine for neuropharmacological and behavioral studies. J Neurosci Methods 2007; 163(1)83–91
   PubMedGoogle Scholar
• Larsen MH, Hay-Schmidt A, Ronn LC, Mikkelsen JD. Temporal expression of brain-derived neurotrophic factor (BDNF) mRNA in the rat hippocampus after treatment with selective and mixed monoaminergic antidepressants. Eur J Pharmacol 2008; 578(2–3)114–122
   PubMedGoogle Scholar
• Madsen TM, Treschow A, Bengzon J, Bolwig TG, Lindvall O, Tingstrom A. Increased neurogenesis in a model of electroconvulsive therapy. Biol Psychiatry 2000; 47(12)1043–1049
   PubMed Web of Science ®Google Scholar
• Rajkowska G, Miguel-Hidalgo JJ. Gliogenesis and glial pathology in depression. CNS Neurol Disord Drug Targets 2007; 6(3)219–233
   PubMedGoogle Scholar
• Rosenberg EH, Almeida LS, Kleefstra T, deGrauw RS, Yntema HG, Bahi N, et al. High prevalence of SLC6A8 deficiency in X-linked mental retardation. Am J Hum Genet 2004; 75(1)97–105
   PubMedGoogle Scholar
• Sanchez C, Bergqvist PB, Brennum LT, Gupta S, Hogg S, Larsen A, et al. Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities. Psychopharmacology (Berlin) 2003; 167(4)353–362
   PubMed Web of Science ®Google Scholar
• Sartorius A, Vollmayr B, Neumann-Haefelin C, Ende G, Hoehn M, Henn FA. Specific creatine rise in learned helplessness induced by electroconvulsive shock treatment. Neuroreport 2003; 14(17)2199–2201
   PubMed Web of Science ®Google Scholar
• Sartorius A, Mahlstedt MM, Vollmayr B, Henn FA, Ende G. Elevated spectroscopic glutamate/gamma-amino butyric acid in rats bred for learned helplessness. Neuroreport 2007; 18(14)1469–1473
   PubMedGoogle Scholar
• Sartorius A, Lugenbiel P, Mahlstedt MM, Ende G, Schloss P, Vollmayr B. Proton magnetic resonance spectroscopic creatine correlates with creatine transporter protein density in rat brain. J Neurosci Methods 2008; 172(2)215–219
   PubMedGoogle Scholar
• Schloss P, Henn FA. New insights into the mechanisms of antidepressant therapy. Pharmacol Ther 2004; 102(1)47–60
   PubMedGoogle Scholar
• Schloss P, Mayser W, Betz H. The putative rat choline transporter CHOT1 transports creatine and is highly expressed in neural and muscle-rich tissues. Biochem Biophys Res Commun 1994; 198(2)637–645
   PubMedGoogle Scholar
• Schulze A, Bachert P, Schlemmer H, Harting I, Polster T, Salomons GS, et al. Lack of creatine in muscle and brain in an adult with GAMT deficiency. Ann Neurol 2003; 53(2)248–251
   PubMed Web of Science ®Google Scholar
• Speer O, Neukomm LJ, Murphy RM, Zanolla E, Schlattner U, Henry H, et al. Creatine transporters: a reappraisal. Mol Cell Biochem 2004; 256–257(1–2)407–424
   PubMedGoogle Scholar
• Sykut-Cegielska J, Gradowska W, Mercimek-Mahmutoglu S, Stockler-Ipsiroglu S. Biochemical and clinical characteristics of creatine deficiency syndromes. Acta Biochim Pol 2004; 51(4)875–882
   PubMed Web of Science ®Google Scholar
• Tachikawa M, Fukaya M, Terasaki T, Ohtsuki S, Watanabe M. Distinct cellular expressions of creatine synthetic enzyme GAMT and creatine kinases uCK-Mi and CK-B suggest a novel neuron-glial relationship for brain energy homeostasis. Eur J Neurosci 2004; 20(1)144–160
   PubMedGoogle Scholar
• Vaidya VA, Terwilliger RZ, Duman RS. Alterations in heavy and light neurofilament proteins in hippocampus following chronic ECS administration. Synapse 2000; 35(2)137–143
   PubMedGoogle Scholar
• Videbech P, Ravnkilde B. Hippocampal volume and depression: a meta-analysis of MRI studies. Am J Psychiatry 2004; 161(11)1957–1966
   PubMed Web of Science ®Google Scholar
• Videbech P, Ravnkilde B, Pedersen TH, Hartvig H, Egander A, Clemmensen K, et al. The Danish PET/depression project: clinical symptoms and cerebral blood flow. A regions-of-interest analysis. Acta Psychiatr Scand 2002; 106(1)35–44
   PubMedGoogle Scholar
• Vollmayr B, Henn FA. Learned helplessness in the rat: improvements in validity and reliability. Brain Res Brain Res Protoc 2001; 8(1)1–7
   PubMedGoogle Scholar
• Walzel B, Speer O, Boehm E, Kristiansen S, Chan S, Clarke K, et al. New creatine transporter assay and identification of distinct creatine transporter isoforms in muscle. Am J Physiol Endocrinol Metab 2002; 283(2)E390–401
   Google Scholar
• Wieronska JM, Klak K, Palucha A, Branski P, Pilc A. Citalopram influences mGlu7, but not mGlu4 receptors' expression in the rat brain hippocampus and cortex. Brain Res 2007; 1184: 88–95
   PubMed Web of Science ®Google Scholar
• Zink M, Rapp S, Gebicke-Haerter PJ, Henn FA, Thome J. Antidepressants differentially affect expression of complexin I and II RNA in rat hippocampus. Psychopharmacology (Berlin) 2005; 181(3)560–565
   PubMedGoogle Scholar